127 related articles for article (PubMed ID: 1310473)
1. Differential expression of the fibronectin isoform containing the ED-B oncofetal domain in normal human fibroblast cell lines originating from different tissues.
Borsi L; Balza E; Allemanni G; Zardi L
Exp Cell Res; 1992 Mar; 199(1):98-105. PubMed ID: 1310473
[TBL] [Abstract][Full Text] [Related]
2. A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors.
Carnemolla B; Balza E; Siri A; Zardi L; Nicotra MR; Bigotti A; Natali PG
J Cell Biol; 1989 Mar; 108(3):1139-48. PubMed ID: 2646306
[TBL] [Abstract][Full Text] [Related]
3. Expression of tenascin and of the ED-B containing oncofetal fibronectin isoform in human cancer.
Nicolò G; Salvi S; Oliveri G; Borsi L; Castellani P; Zardi L
Cell Differ Dev; 1990 Dec; 32(3):401-8. PubMed ID: 1711919
[TBL] [Abstract][Full Text] [Related]
4. Oncofetal fibronectins in oral carcinomas: correlation of two different types.
Mandel U; Gaggero B; Reibel J; Therkildsen MH; Dabelsteen E; Clausen H
APMIS; 1994 Sep; 102(9):695-702. PubMed ID: 7946273
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta regulates the splicing pattern of fibronectin messenger RNA precursor.
Borsi L; Castellani P; Risso AM; Leprini A; Zardi L
FEBS Lett; 1990 Feb; 261(1):175-8. PubMed ID: 2307231
[TBL] [Abstract][Full Text] [Related]
6. The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis.
Castellani P; Viale G; Dorcaratto A; Nicolo G; Kaczmarek J; Querze G; Zardi L
Int J Cancer; 1994 Dec; 59(5):612-8. PubMed ID: 7525495
[TBL] [Abstract][Full Text] [Related]
7. Procedure for the purification of the fibronectin proteolytic fragments containing the ED-B oncofetal domain.
Borsi L; Balza E; Leprini A; Ponassi M; Zardi L
Anal Biochem; 1991 Feb; 192(2):372-9. PubMed ID: 2035837
[TBL] [Abstract][Full Text] [Related]
8. Qualitative and quantitative changes of human tenascin expression in transformed lung fibroblast and lung tumor tissues: comparison with fibronectin.
Oyama F; Hirohashi S; Shimosato Y; Titani K; Sekiguchi K
Cancer Res; 1991 Sep; 51(18):4876-81. PubMed ID: 1716516
[TBL] [Abstract][Full Text] [Related]
9. The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma.
Matsuura H; Hakomori S
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6517-21. PubMed ID: 2995969
[TBL] [Abstract][Full Text] [Related]
10. Distribution of fibronectin isoforms in human renal disease.
Van Vliet A; Baelde HJ; Vleming LJ; de Heer E; Bruijn JA
J Pathol; 2001 Feb; 193(2):256-62. PubMed ID: 11180174
[TBL] [Abstract][Full Text] [Related]
11. Patterns of alternative splicing of fibronectin pre-mRNA in human adult and fetal tissues.
Oyama F; Murata Y; Suganuma N; Kimura T; Titani K; Sekiguchi K
Biochemistry; 1989 Feb; 28(3):1428-34. PubMed ID: 2713373
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy.
Siddiqui I; Khan ZA; Lian D; Jiang J; Zhong R; Garcia B; Chakrabarti S
Transplantation; 2006 Aug; 82(3):406-14. PubMed ID: 16906041
[TBL] [Abstract][Full Text] [Related]
13. Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon.
Zardi L; Carnemolla B; Siri A; Petersen TE; Paolella G; Sebastio G; Baralle FE
EMBO J; 1987 Aug; 6(8):2337-42. PubMed ID: 2822387
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing of the angiogenesis associated extra-domain B of fibronectin regulates the accessibility of the B-C loop of the type III repeat 8.
Ventura E; Sassi F; Parodi A; Balza E; Borsi L; Castellani P; Carnemolla B; Zardi L
PLoS One; 2010 Feb; 5(2):e9145. PubMed ID: 20161770
[TBL] [Abstract][Full Text] [Related]
15. ED-B fibronectin in non-small cell lung carcinoma.
Khan ZA; Caurtero J; Barbin YP; Chan BM; Uniyal S; Chakrabarti S
Exp Lung Res; 2005 Sep; 31(7):701-11. PubMed ID: 16203624
[TBL] [Abstract][Full Text] [Related]
16. Source of oncofetal ED-B-containing fibronectin: implications of production by both tumor and endothelial cells.
Midulla M; Verma R; Pignatelli M; Ritter MA; Courtenay-Luck NS; George AJ
Cancer Res; 2000 Jan; 60(1):164-9. PubMed ID: 10646869
[TBL] [Abstract][Full Text] [Related]
17. Expression of extra domain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent.
Glukhova MA; Frid MG; Shekhonin BV; Vasilevskaya TD; Grunwald J; Saginati M; Koteliansky VE
J Cell Biol; 1989 Jul; 109(1):357-66. PubMed ID: 2663879
[TBL] [Abstract][Full Text] [Related]
18. Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts.
Pujuguet P; Hammann A; Moutet M; Samuel JL; Martin F; Martin M
Am J Pathol; 1996 Feb; 148(2):579-92. PubMed ID: 8579120
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts.
Balza E; Borsi L; Allemanni G; Zardi L
FEBS Lett; 1988 Feb; 228(1):42-4. PubMed ID: 3422628
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells.
Borsi L; Carnemolla B; Castellani P; Rosellini C; Vecchio D; Allemanni G; Chang SE; Taylor-Papadimitriou J; Pande H; Zardi L
J Cell Biol; 1987 Mar; 104(3):595-600. PubMed ID: 3643927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
